机译:CFTR校正器和增强剂组合治疗患者F508DEL-CFTR纯合突变患者的疗效和安全性:系统评价和荟萃分析
Sichuan Univ West China Hosp Dept Resp &
Crit Care Med Chengdu Sichuan Peoples R China;
Sichuan Univ West China Hosp Dept Resp &
Crit Care Med Chengdu Sichuan Peoples R China;
Sichuan Univ West China Hosp Dept Resp &
Crit Care Med Chengdu Sichuan Peoples R China;
Chengdu Second Peoples Hosp Dept Resp Med Chengdu Sichuan Peoples R China;
Suining Municipal Hosp TCM Dept Neurosurg Suining Peoples R China;
Sichuan Univ West China Hosp Dept Resp &
Crit Care Med Chengdu Sichuan Peoples R China;
Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Ivacaftor; Lumacaftor; Tezacaftor;
机译:CFTR校正器和增强剂组合治疗患者F508DEL-CFTR纯合突变患者的疗效和安全性:系统评价和荟萃分析
机译:Lumacafactor和Ivacafacter在6-11岁患者中患者的疗效和安全性,囊性纤维化纯合纯合 - C508DEL-CFTR:随机,安慰剂控制,第3阶段试验(Vol 5 PG 557,2017)
机译:Lumacafactor和Ivacafactor在6-11岁患者中患者囊性纤维化术纯合的疗效和安全性F508del-CFTR:随机,安慰剂控制,第3阶段试验
机译:抑郁症患者的抗抑郁药,认知行为治疗和组合治疗:系统审查和荟萃分析
机译:体外冲击波治疗与低水平激光治疗对脑隧道综合征的成人患者疼痛和症状严重程度及函数状况的疗效:系统评价与荟萃分析
机译:Lumacaftor-ivacaftor治疗纯合F508del-CFTR突变的囊性纤维化患者的疗效
机译:WS7.3 VX-661,研究性CFTR校正剂,与ivacaftor(CFTR增强剂)组合,用于CF和F508Del-CFTR突变纯合子患者:中期分析